Otc - Active Ingredient
Active Ingredient Purpose
Lidocaine Base USP 9.6% w/w (approximately 10 mg per spray) Topical Analgesic
The following Structured Product Label (SPL) was submitted to the FDA by Fleet Laboratories Ltd for the product Premjact Male Desensitizer (NDC 70233-004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, inactive ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active Ingredient Purpose
Lidocaine Base USP 9.6% w/w (approximately 10 mg per spray) Topical Analgesic
Use temporarily reduces sensitivity of the penis, which helps to delay ejaculation in cases of over-rapid or premature ejaculation (coming to a climax too quickly
Keep out of reach of children
Stop use and consult a doctor
Warnings
For external use only
Allergy alert: do not use this product if you or your partner are allergic (sensitive) to local anesthetics
Do not use
Ask a doctor before use if you have, or ever had, liver or kidney problems
Ask a doctor or pharmacist before use if you are already taking prescribed drugs
When using this product
directions
There are no inactive ingredients
* Please review the disclaimer below.